Atazanavir/cobicistat
id:
atazanavir-cobicistat-0-15623655
title:
Atazanavir/cobicistat
text:
Atazanavir/cobicistat, sold under the brand name Evotaz, is a fixed-dose combination antiretroviral medication used to treat and prevent HIV/AIDS. It contains atazanavir and cobicistat. Atazanavir is an HIV protease inhibitor and cobicistat is an inhibitor of cytochrome P450 (CYP) enzymes of the CYP3A family. Atazanavir/cobicistat was approved by the Food and Drug Administration (FDA) for medical use in United States in January 2015. It was approved for medical use in the European Union in July
brand slug:
wiki
category slug:
encyclopedia
description:
Combination drug for HIV
original url:
https://en.wikipedia.org/wiki/Atazanavir/cobicistat
date created:
date modified:
2023-12-02T07:01:06Z
main entity:
{"identifier":"Q28859614","url":"https://www.wikidata.org/entity/Q28859614"}
image:
fields total:
13
integrity:
14